TITLE

Effects of Antiretroviral Drug Recall on Perception of Therapy Benefits and on Adherence to Antiretroviral Treatment in HIV-Infected Children

AUTHOR(S)
Giannattasio, Antonietta; Barbarino, Alessandro; Vecchio, Andrea Lo; Bruzzese, Eugenia; Mango, Carmela; Guarino, Alfredo
PUB. DATE
September 2009
SOURCE
Current HIV Research;Sep2009, Vol. 7 Issue 5, p468
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In June 2007, the European Medicines Agency announced the recall by Roche of nelfinavir from European Union markets because of contamination of tablets with ethyl mesylate. Based on this event, we investigated the effect of switching therapy because of nelfinavir recall or for other reasons on the perception of therapy benefits and adherence to treatment in HIV-infected children and their caregivers. Thirty-eight children (mean age 12.1±6.7 years) were enrolled. A 35-item questionnaire was administered to the caregivers of enrolled children. Adherence was evaluated through a 4-day recall adherence instrument. Enrolled children were divided into 3 groups: patients who were shifted because of nelfinavir recall (group A, 8 patients); patients who were shifted for other reasons (group B, 12 patients); patients who were not shifted in the last 6 months (group C, 18 patients). All caregivers considered antiretroviral therapy necessary and effective for their children. However, drug shifting generated anxiety in most of them, irrespective of the reason for shifting. At baseline, 74% patients adhered to therapy. Adherence rate was related to the type of caregivers being higher in children cared for by foster parents than in children cared for by biological parents or second-degree relatives. Adherence rates did not change significantly in groups A and B after switching. Drug-switching raises concern in caregivers of HIV-infected children and induces a negative feeling irrespective of the reason for switching. However, switching, including the shift due to nelfinavir recall, did not affect adherence rates.
ACCESSION #
52416644

 

Related Articles

  • Efectos del tiempo de infección sobre predictores de adherencia en personas con VIH. Piña López, Julio Alfonso; Tapia, Mariana Dávila; Sánchez Sosa, Juan José; Robles, Óscar Cázares; Togawa, Carlos; Corrales Rascón, Andrés Ernesto // International Journal of Psychology & Psychological Therapy;2009, Vol. 9 Issue 1, p67 

    A cross-sectional study was made with the main objective to prove the effects of length of infection (in months) on predictors of adherence behaviors to antiretroviral therapy in a sample of 44 persons with HIV. A multiple linear regression analysis showed that motives and stress-related to high...

  • Spread of drug-resistant HIV.  // Bulletin of the World Health Organization;1999, Vol. 77 Issue 10, p860 

    Reports the spread of drug-resistant strains of human immunodeficiency virus (HIV) among HIV infected individuals in Geneva, Switzerland. Study on HIV infected individuals from 1996 to 1998; Evidence of virus samples resistant to first-generation antiviral drugs; Need for intensifying public...

  • Forgiveness of non-adherence to HIV-1 antiretroviral therapy.  // Journal of Antimicrobial Chemotherapy (JAC);Apr2008, Vol. 61 Issue 4, p769 

    Superior adherence to HIV-1 antiretroviral therapy is a mainstay of successful HIV management. Studies performed in the early era of highly active antiretroviral therapy demonstrated the need for ≥95% adherence in order to achieve and sustain viral suppression. High rates of viral...

  • Antiretroviral activity of pegylated interferon alfa-2a in patients co-infected with HIV/hepatitis C virus. D. Aguilar Marucco; L. Veronese; D. Gonzalez de Requena; S. Bonora; A. Calcagno; I. Cavecchia; A. Sinicco; F. G. De Rosa; G. Cariti; G. Di Perri // Journal of Antimicrobial Chemotherapy (JAC);Mar2007, Vol. 59 Issue 3, p565 

    Objectives To evaluate the early anti-HIV activity of pegylated interferon (PEG-IFN) alfa-2a and ribavirin in HIV/hepatitis C virus (HCV) co-infected patients not receiving antiretroviral therapy. Patients and methods In 19 patients with baseline plasma HIV...

  • Physician Beliefs about Antiretroviral Adherence Communication. Roberts, Kathleen Johnston // AIDS Patient Care & STDs;Sep2000, Vol. 14 Issue 9, p477 

    Adherence to antiretroviral regimens is thought to be imperative for HIV-positive patients. However, little is known about health care professionals' willingness to discuss adherence with patients, nor what barriers, if any, may impede their adherence communication. The aims of the study were to...

  • Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of ‘Universal Access’. Harries, Anthony D.; Makombe, Simon D.; Schouten, Erik J.; Ben-Smith, Anne; Jahn, Andreas // Transactions of the Royal Society of Tropical Medicine & Hygiene;Apr2008, Vol. 102 Issue 4, p310 

    Summary: In 10 years, in line with the concept of universal access, 25 million HIV-infected patients in sub-Saharan Africa might be on antiretroviral therapy (ART). There are different models of ART delivery, from the individualised, medical approach to the simple, public health approach, both...

  • Is average adherence to HIV antiretroviral therapy enough? Bangsberg, David R.; Deeks, Steven G. // JGIM: Journal of General Internal Medicine;Oct2002, Vol. 17 Issue 10, p812 

    Comments on an article on the adherence behavior of several HIV-infected people to antiretroviral therapy. Assessment of the biological relationship between adherence and antiretroviral drug resistance; Factors that contribute to the apparent disconnect between virologic failure, drug...

  • A prospective study of predictors of adherence to combination antiretroviral medication. Golin, Carol E.; Liu, Honghu; Hays, Ron D.; Miller, Loren G.; Beck, C. Keith; Ickovics, Jeanette; Kaplan, Andrew H.; Wenger, Neil S. // JGIM: Journal of General Internal Medicine;Oct2002, Vol. 17 Issue 10, p756 

    Objective: Adherence to complex antiretroviral therapy (ART) is critical for HIV treatment but difficult to achieve. The development of interventions to improve adherence requires detailed information regarding barriers to adherence. However, short follow-up and inadequate adherence...

  • THE USING OF ARV PATTERN TO PATIENTS ON HIV/AIDS IN UPIPI Dr. SOETOMO HOSPITAL, SURABAYA, JANUARY - JUNE 2011. Sari, Retno Juwita; Srihartini, Indah; Triyono, Erwin Astha // Folia Medica Indonesiana;2013, Vol. 49 Issue 3, p182 

    This study aims to determine how patterns of use of antiretroviral agents in HIV/AIDS patients in UPIPI RSUD Dr. Soetomo during January-June 2011. The method of the study conducted retrosprektif observational data and analyzed using descriptive. The results showed than 202 patients, ARV regimens...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics